论文部分内容阅读
目的 探究肘静脉压测定指导心力衰竭治疗的临床效果.方法 方便选取该院2016年1月—2017年6月进行治疗的72例心力衰竭患者,分为观察组及对照组,各36例.两组均取常规治疗,观察组按照患者肘静脉压测定值、体液潴留情况和评估心功能指导用药,对照组按照患者临床症状、体征、评估心功能指导用药.对比两组治疗后的住院时间、费用、症状和血压改善的时间,以及治疗后临床疗效和心功能指标.结果 观察组LVEDV、LVESV、LVEF在治疗前分别为:(100.42±28.62)mL、(149.81±45.93)mL、(32.97±7.03)％;对照组LVEDV、LVESV、LVEF在治疗前分别为:(99.64±28.44)mL、(149.62±45.37)mL、(32.85±6.95)％,两组对比,差异无统计学意义(P>0.05).治疗后,观察组LVEDV、LVESV、LVEF分别为:(65.26±16.90)mL、(131.08±36.93)mL、(55.14±11.26)％;对照组LVEDV、LVESV、LVEF在治疗后分别为:(79.63±14.34)mL、(138.47±40.27)mL、(44.72±10.37)％,相较于对照组,观察组的LVEF较高,而LVEDV、LVESV较低,差异有统计学意义(t=5.214,2.248,3.147,P<0.05).观察组住院时间、症状改善时间、住院费用、血压改善时间分别为(13.9±5.0)d、(4.7±1.9)d、(10272.05)元、(8.7±2.6)d,对照组住院时间、症状改善时间、住院费用、血压改善时间分别为(17.8±6.7)d、(7.1±3.3)d、(12612.30)元、(13.6±4.7)d,差异有统计学意义(t=0.556,8.587,2.541,5.487,P<0.05).治疗后对照组的治疗有效率72.22％,而观察组是94.44％,差异有统计学意义(χ2=1.147,P0.05). After treatment，the observation group LVEDV， LVESV， LVEF were: (65.26±16.90)mL, (131.08±36.93)mL, (55.14±11.26)%; the control group LVEDV, LVESV， LVEF were: (79.63±14.34)mL after treatment, (138.47±40.27)mL, (44.72±10.37)%, compared with the control group, the LVEF of the observation group was higher, while the LVEDV and LVESV were lower. The data of the two groups met the condition (t=5.214, 2.248, 3.147, P<0.05). The hospitalization time, symptom improvement time, hospitalization cost, and blood pressure improvement time of the observation group were (13.9±5.0)d, (4.7±1.9)d, (10272.05) yuan, (8.7±2.6)d, and the hospital stay in the control group and symptoms improved. The time, hospitalization cost, and blood pressure improvement time were (17.8±6.7)d, (7.1±3.3)d, (12612.30) yuan, and (13.6±4.7)d, respectively. The data of the two groups met the condition, was statistically significant (t=0.556, 8.587, 2.541, 5.487, P<0.05). After treatment, the effective rate of the control group was 72.22%, while that of the observation group was 94.44% (X2=1.147, P<0.05), which was statistically significant. Conclusion The use of elbow venous pressure to guide the treatment in patients with heart failure can speed up the recovery of patients, relieve clinical symptoms, improve patients’ quality of life, reduce hospitalization costs, shorten patient hospitalization time, improve heart function, and have clinical application value.